PA8800201A1 - Productos quimioterapéuticos cristalinos - Google Patents

Productos quimioterapéuticos cristalinos

Info

Publication number
PA8800201A1
PA8800201A1 PA20088800201A PA8800201A PA8800201A1 PA 8800201 A1 PA8800201 A1 PA 8800201A1 PA 20088800201 A PA20088800201 A PA 20088800201A PA 8800201 A PA8800201 A PA 8800201A PA 8800201 A1 PA8800201 A1 PA 8800201A1
Authority
PA
Panama
Prior art keywords
crystal
chemotherapeutic products
chemotherapeutic
products
lamism
Prior art date
Application number
PA20088800201A
Other languages
English (en)
Inventor
B Borchardt Thomas
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40090209&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PA8800201(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PA8800201A1 publication Critical patent/PA8800201A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

GORMA CRISTALINA 1 DE N-[4-(3-AMINO-1H-INDAZOI-4-IL)FENIL]-N'-(2-FLUORO-5-METIFENIL)UREA HIDRATO, MANERAS PARA ELABORARLA, FORMULACIONES QUE COMPRENDEN A LA MISMA Y ELABORADAS CON LAMISMA Y MÈTODOS DE TRATAMIENTO DE PACIENTES QUE PADECEN UNA ENFERMEDAD PARA USARLA.
PA20088800201A 2007-10-19 2008-10-17 Productos quimioterapéuticos cristalinos PA8800201A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98123607P 2007-10-19 2007-10-19

Publications (1)

Publication Number Publication Date
PA8800201A1 true PA8800201A1 (es) 2009-05-15

Family

ID=40090209

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20088800201A PA8800201A1 (es) 2007-10-19 2008-10-17 Productos quimioterapéuticos cristalinos

Country Status (24)

Country Link
US (2) US7947843B2 (es)
EP (1) EP2195298B1 (es)
JP (1) JP5517940B2 (es)
KR (1) KR20100085116A (es)
CN (1) CN101827822B (es)
AR (1) AR068917A1 (es)
AU (1) AU2008312529A1 (es)
BR (1) BRPI0818065A8 (es)
CA (1) CA2699352C (es)
CL (1) CL2008003090A1 (es)
CO (1) CO6280481A2 (es)
CR (1) CR11388A (es)
DO (1) DOP2010000115A (es)
EC (1) ECSP10010188A (es)
ES (1) ES2460951T3 (es)
MX (1) MX2010004286A (es)
PA (1) PA8800201A1 (es)
PE (1) PE20091385A1 (es)
RU (1) RU2010119928A (es)
SG (1) SG185327A1 (es)
TW (1) TW200934485A (es)
UA (1) UA99746C2 (es)
UY (1) UY31407A1 (es)
WO (1) WO2009052226A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7947843B2 (en) * 2007-10-19 2011-05-24 Abbott Laboratories Crystalline chemotherapeutic
US8759538B1 (en) 2013-06-13 2014-06-24 Abbvie Inc. Crystalline chemotherapeutic

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297709B2 (en) * 2003-05-22 2007-11-20 Abbott Laboratories Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
SI1638941T1 (sl) * 2003-05-22 2010-11-30 Abbott Lab Inhibitorji indazol benzizoksazol in benzizotiazol kinaze
EP1925941B1 (en) * 2005-08-01 2012-11-28 Eisai R&D Management Co., Ltd. Method for prediction of the efficacy of vascularization inhibitor
JP4989476B2 (ja) * 2005-08-02 2012-08-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 血管新生阻害物質の効果を検定する方法
US20070104780A1 (en) 2005-10-25 2007-05-10 Lipari John M Formulation comprising a drug of low water solubility and method of use thereof
US20070149593A1 (en) * 2005-12-23 2007-06-28 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
EP2089003A1 (en) * 2006-11-09 2009-08-19 Abbott GmbH & Co. KG Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
US7947843B2 (en) * 2007-10-19 2011-05-24 Abbott Laboratories Crystalline chemotherapeutic

Also Published As

Publication number Publication date
CL2008003090A1 (es) 2009-11-27
JP2011500705A (ja) 2011-01-06
CN101827822A (zh) 2010-09-08
MX2010004286A (es) 2010-04-30
ES2460951T3 (es) 2014-05-16
TW200934485A (en) 2009-08-16
UA99746C2 (ru) 2012-09-25
RU2010119928A (ru) 2011-11-27
EP2195298A1 (en) 2010-06-16
DOP2010000115A (es) 2010-10-15
SG185327A1 (en) 2012-11-29
BRPI0818065A8 (pt) 2016-03-08
BRPI0818065A2 (pt) 2015-03-31
US20110196010A1 (en) 2011-08-11
UY31407A1 (es) 2009-05-29
CA2699352C (en) 2016-06-21
WO2009052226A1 (en) 2009-04-23
EP2195298B1 (en) 2014-02-19
ECSP10010188A (es) 2010-06-29
CA2699352A1 (en) 2009-04-23
CN101827822B (zh) 2013-06-19
AR068917A1 (es) 2009-12-16
CO6280481A2 (es) 2011-05-20
JP5517940B2 (ja) 2014-06-11
PE20091385A1 (es) 2009-11-12
KR20100085116A (ko) 2010-07-28
US8486988B2 (en) 2013-07-16
US20090118344A1 (en) 2009-05-07
CR11388A (es) 2010-10-05
US7947843B2 (en) 2011-05-24
AU2008312529A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
CO6430467A2 (es) Péptidos útiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosméticas o farmacéuticas
EA200900177A1 (ru) Замещенные ациланилиды и способы их применения
EA200802208A1 (ru) Применение флибансерина для лечения расстройств полового влечения в постклимактерический период
UY29777A1 (es) Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos del sueno en pacientes con depresión.
ATE513562T1 (de) Nicht-spezifische immunstimulierende mittel
CL2011000806A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular.
MY143269A (en) Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder
CL2012001671A1 (es) Compuestos derivados de (metilsulfonil)-etil-bencenoisoindolina; composicion farmaceutica que los comprende, uso en el tratamiento del cancer, dolor, trastornos del snc, enfermedades dermatologicas, entre otras.
GT200900319A (es) (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y su uso en el campo de la coagulación sanguínea
CR11443A (es) Productos quimioterapeuticos cristalinos
DOP2010000111A (es) Productos quimioterapeuticos cristalinos
PA8800201A1 (es) Productos quimioterapéuticos cristalinos
ECSP077843A (es) Tratamiento o prevención del prurito
UY31790A (es) Utilización de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia y que tienen un incremento del nivel de creatinina debido a la administración de dronedarona
DOP2010000113A (es) Productos quimioterapeuticos cristalinos
CR9074A (es) Agente para la profilaxis o tratamiento del sindrome metabolico
CY1111361T1 (el) Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια
ME00489B (me) NOVA SINERGIČKA KOMBINACIJA KOJA UKLJUČUJE ROFLUMILAST l FERMOTEROL
PA8624501A1 (es) Piperazinas derivadas de úrea para el tratamiento de la endometrosis
TWD168858S (zh) 一種脛骨近端後內側平台固定骨板
ITRM20040040A1 (it) Vaccino per la cura di vecchiaia e morte.